ChristopherTBeverMD

Neurology • Baltimore, MD

Professor, Neurology, University of Maryland School of Medicine

Join to view full profile

Are you Dr. Bever?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 70 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
16 S Eutaw St
Frenkil Bldg 3RD FL
Baltimore, MD 21201
Phone+1 410-328-4323

Fax+1 410-328-1149

Summary

Dr. Christopher Bever, MD is a board certified neurologist in Baltimore, Maryland. He is currently licensed to practice medicine in Maryland, Tennessee, and New Jersey. He is affiliated with Veterans Affairs Maryland Health Care System-Baltimore Division and University of Maryland Medical Center.

Education & Training

New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 1977 - 1980
Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 1976 - 1977
University of Cincinnati Medical Center/College of MedicineInternship, Internal Medicine, 1975 - 1976
University of Rochester School of Medicine and DentistryClass of 1975

Certifications & Licensure

NJ State Medical License 1976 - Present
MD State Medical License 1987 - 2026
TN State Medical License 1985 - 1987
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Robotic Upper-Limb Neurorehabilitation in Chronic Stroke Patient Start of enrollment: 2002 Apr 01
Completed
Phase 2
Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis Start of enrollment: 2005 Apr 01
Completed
Phase 2
Evaluation of Robotic Arm Rehabilitation in Stroke Patients Start of enrollment: 2006 Jun 01
Completed
Not Applicable
Treadmill Training in Chronic MS: Efficacy and Cost-effectiveness Start of enrollment: 2006 Apr 01
Withdrawn
Not Applicable
Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis Start of enrollment: 2006 Dec 01
Unknown status
Phase 1
Improving Neuropathy and Mobility in People With Early Diabetes Start of enrollment: 2009 Nov 01
Completed
Not Applicable
Evaluation of Robot Assisted Neuro-Rehabilitation Start of enrollment: 2011 Apr 27
Completed
Phase 1, Phase 2
Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis Start of enrollment: 2011 Mar 01
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

124 citations
Hematopoietic progenitors express neural genes
James E. Goolsby, Marie C. Marty, Dafna Heletz, Joshua Chiappelli, Gerti Tashko
Proceedings of the National Academy of Sciences of the United States of America. 2003-12-09
127 citations
Evidence-based guideline: Assessment and management of psychiatric disorders in individuals with MS: Report of the Guideline Development Subcommittee of the American A...
Sarah L. Minden, Anthony Feinstein, Rosalind Kalb, Deborah M. Miller, David C. Mohr
Neurology. 2014-01-14
13 citations
Induction of RANTES chemokine expression in human astrocytic cells is dependent upon activation of NF-kappaB transcription factor.
Qingdi Li, Christopher T. Bever, David R. Burt, Susan I.V. Judge, G. Trisler
International Journal of Molecular Medicine. 2001-05-01

Press Mentions

VA Maryland Health Care System Surgeon and Researcher Finds Way to Prevent Vascular ScarringNovember 20th, 2015

Professional Memberships

American Academy of Neurology - AAN
Member